Drugs Affecting Growth of Tumours -

Drugs Affecting Growth of Tumours

Buch | Hardcover
IX, 238 Seiten
2006 | 2006
Springer Basel (Verlag)
978-3-7643-2196-3 (ISBN)
181,89 inkl. MwSt
During recent years the field of effective anticancer agents has substantially increased. The use of chemotherapy has been accepted as a standard therapy for an expanding number of tumour types and stages, while many new agents are being investigated when standard therapy is lacking or failing. Apart from new targets for anticancer agents, attention is also focused on improving efficacy and tolerability of existing compounds.
This topical volume provides an up-to-date overview of clinically relevant data on anticancer agents, and is not only intended for those working as a medical doctor with cancer patients, but also for medical researchers and students. The different classes of anticancer drugs are described by international authorities on the various topics.

Antimetabolites.- DNA-intercalators — the anthracyclines.- Topoisomerase inhibitors.- Tubulin interacting agents.- Vaccination therapies in solid tumors.- Oral anticancer agents.- Anti-angiogenesis agents.- Signal transduction inhibitors.- Endocrine therapy of breast cancer.

Erscheint lt. Verlag 14.6.2006
Reihe/Serie Milestones in Drug Therapy
Zusatzinfo IX, 238 p.
Verlagsort Basel
Sprache englisch
Maße 170 x 244 mm
Gewicht 700 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Schlagworte angiogenesis • Anti-cancer Drugs • Breast Cancer • Cancer • Chemotherapy • Drug • New Drug Targets • Pharmakotherapie • Research • signal transduction • Therapy of Cancer • Tumor • Tumors • Tumour Growth • Vaccination
ISBN-10 3-7643-2196-2 / 3764321962
ISBN-13 978-3-7643-2196-3 / 9783764321963
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
27,00

von Stein Husebø; Gebhard Mathis; Eva Katharina Masel

Buch | Softcover (2023)
Springer (Verlag)
49,99